TwitterLinkedInFacebook Instagram
United StatesLanguage Flag

Press Release

OraSure Technologies to Participate at the William Blair 2011 Life Sciences Conference

September 1, 2011 at 6:01 AM EDT

BETHLEHEM, Pa., Sep 1, 2011 (GlobeNewswire via COMTEX) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Dr. Stephen R. Lee, Chief Science Officer & EVP R&D, will participate on a panel at the William Blair 2011 Life Sciences Conference in New York City. The panel discussion will be simultaneously webcast over the Internet.

Dr. Lee is scheduled to participate on the Hepatitis C Value Chain panel September 7, 2011, at approximately 3:20 pm Eastern Time (12:20 pm Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies' web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies' web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link http://www.wsw.com/webcast/blair43/panel4.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the Company also is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.

The OraSure Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6440

For more information on OraSure Technologies, please visit www.orasure.com.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: OraSure Technologies, Inc.

CONTACT: Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
© OraSure Technologies., 2024